Darunavir
PREZISTA, darunavir
Protease Inhibitor
NADAC/unit
$1.1309
No Shortage
Tier 1: 92.4%
10 Manufacturers
23 ANDAs
Darunavir, co-administered with ritonavir (darunavir/ritonavir), in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV-1) infection in....
vs. brand PREZISTA: Generic saves up to 89% per unit
Generic Manufacturers
AMNEAL EU LTDANNORA PHARMA PRIVATE LTDAUROBINDO PHARMA LTDCIPLA LTDDR REDDYS LABORATORIES LTDHETERO LABS LTD UNIT IIIJANSSEN PRODUCTS LPLUPIN LTDMSN LABORATORIES PRIVATE LTDMYLAN PHARMACEUTICALS INCZYDUS LIFESCIENCES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.